Nautilus Biotechnology, Inc., headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in protein analysis and quantification. Founded in 2016, Nautilus has rapidly established itself as a leader in the field, leveraging its innovative platform to provide unparalleled insights into proteomics. The company’s core offering, the Nautilus Proteomics Platform, distinguishes itself through its ability to deliver high-throughput, accurate protein measurements, which are essential for advancing drug discovery and personalised medicine. With a commitment to transforming the understanding of biology, Nautilus has achieved significant milestones, including strategic partnerships and advancements in technology that enhance its market position. As a key player in the biotechnology landscape, Nautilus Biotechnology continues to push the boundaries of scientific research, making substantial contributions to the life sciences industry.
How does Nautilus Biotechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Nautilus Biotechnology, Inc.'s score of 23 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nautilus Biotechnology, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the biotechnology sector. As the industry increasingly focuses on sustainability, it is essential for companies like Nautilus to establish clear climate commitments and measurable targets to align with global efforts in reducing greenhouse gas emissions.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nautilus Biotechnology, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.